Artificial intelligence could be better than you think
Will GSK's move towards licensing patents in developing countries, rather than rigidly defending them, improve access to medicines?
There's more to influencing the science of change than temperature and catalysts
Counting the cost of regulation is more than a numbers game
Should trade bodies do more than simply 'represent their members' interests'?
Academic freedom is a cornerstone of society that needs protection from governments that seek to silence freethinkers
Could the debate over pharma price-gouging have positive results for both patients and companies?
Science fiction or science future?
Chemists need to get their own house (or lab cupboard) in order and new electronic inventories are just the ticket
Keeping the public’s trust is our shared duty
Being a number can make scientists more unique
New elements mean more than just new names
Great stories can change hearts and minds
Making it more attractive for companies to develop paediatric drugs has the potential to improve everyone’s lives
Perovskite-based solar cells were a hot ticket in Boston this December
Our environmental ambitions are only as good as the companies we keep
With major funding cuts averted, UK chemists prepare to take on some of the world's biggest challenges
2015 went out with a bang in terms of mergers
Michael Faraday is the father of Christmas science
Companies have to tread a little carefully when it comes to advertising prescription drugs
The UK research landscape is in a state of flux and decisions made now will dictate its direction for many years
If the prize is right, it means more than recognition
Just because something is legal, doesn’t mean it’s the right thing to do
Cheating on emissions tests means cheating people of their health
Heralding a renaissance in science communication